Search results
Man dies after record 613-day infection with COVID-19, researchers say
WAFB Baton Rouge· 1 day agoThe case was highlighted in a news release from the American Association for the Advancement of...
Infected blood scandal: Children were used as 'guinea pigs' in clinical trials
BBC via AOL· 6 days agoThey continued for more than 15 years, involved hundreds of people, and infected most with hepatitis...
The Difference Between Feeling Anxious and Having an Anxiety Disorder
Dr. Samantha Boardman via Yahoo News· 9 hours agoFeeling anxious can be a deeply uncomfortable experience. It’s also perfectly normal. Just because...
Understanding Benzodiazepines and How They Work
Verywell Health via Yahoo News· 10 hours agoBenzodiazepines (also known as benzos) are a class of medications used to treat anxiety disorders, seizures, insomnia, and other health conditions. While...
Sanofi wins in late-stage trial for blood disorder candidate (NASDAQ:SNY)
Seeking Alpha· 1 day agoSanofi's (SNY) oral therapy, rilzabrutinib, shows promise in a Phase 3 trial for an autoimmune blood...
Man Dies After Having COVID for 613 Days
People via Yahoo News· 5 days agoThe 72-year-old patient, who had a blood disorder, first contracted a variant of the virus in February 2022 — and it had over 50 mutations Getty Images...
Signs and Symptoms of Diabetes Insipidus
Health via Yahoo News· 7 hours agoThis type of diabetes insipidus can happen for several reasons, including due to lithium use (a medication for bipolar disorder) or severe electrolyte...
Boy with rare blood disorder receives new life-changing gene therapy treatment
FOX 5 New York· 6 days agoNEW YORK - Yusuf Saeed is smiling behind his mask, and he has every reason to. The 8-year-old was...
Could low-dose naltrexone ease arthritis pain?
Seattle Times· 11 hours agoQ: I have painful osteoarthritis throughout my body. Because I am on the blood thinner Pradaxa for life, I am not able to take aspirin or NSAIDs for the pain. A: Naltrexone ...
Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study
Zacks via Yahoo Finance· 1 day agoSanofi's (SNY) BTK inhibitor, rilzabrutinib, demonstrates durable platelet response in the phase III...